Send me a link:

*Text messaging rates may apply.

 Dow Up 0.21% Nasdaq Up 0.11%

Exelixis, Inc. (EXEL)

-NasdaqGS
4.44 Up 0.25(5.97%) 1:40PM EDT - Nasdaq Real Time Price
Prev Close:4.19
Open:4.20
Bid:4.42 x 23200
Ask:4.43 x 2000
1y Target Est:6.07
Beta:2.26
Next Earnings Date:31-Jul-14EXEL Earnings announcement
Day's Range:4.08 - 4.55
52wk Range:3.02 - 8.41
Volume:7,409,802
Avg Vol (3m):3,851,300
Market Cap:864.44M
P/E (ttm):N/A
EPS (ttm):-1.48
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
EXELUp 5.97%864.44M
AZNDown 0.73%93.24B
GSKDown 0.78%115.82B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):30.70
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-1.57
Quarterly EPS Est (Jun-14) :-0.39
Mean Recommendation*:2.3
PEG Ratio (5 yr expected):0.11

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Exelixis, Inc., a biotechnology company, develops small molecule therapies for the treatment of cancer in the United States. The company focuses primarily on developing and commercializing COMETRIQ, an inhibitor of multiple receptor tyrosine kinas... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback